Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
ESAIY
)
6.740
-0.020 (-0.30%)
Streaming Delayed Price
Updated: 12:59 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
66,745
Open
6.520
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
6.760
Today's Range
6.520 - 6.740
52wk Range
6.520 - 13.15
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
Shanghai Multitude Therapeutics out-licensed global rights for its Tissue Factor ADC to Adcendo in a $1 billion agreement. The value of the agreement includes upfront and milestone payments, with...
Via
Talk Markets
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
August 22, 2024
The U.K.'s Medicines and Healthcare products Regulatory Agency approved Eisai and Biogen's Leqembi for treating mild cognitive impairment and mild dementia due to Alzheimer's. Despite this, NICE stated...
Via
Benzinga
Performance
YTD
-45.45%
-45.45%
1 Month
-11.32%
-11.32%
3 Month
-30.80%
-30.80%
6 Month
-34.82%
-34.82%
1 Year
-45.23%
-45.23%
More News
Read More
Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED
August 17, 2024
Via
Talk Markets
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug
July 26, 2024
Via
Investor's Business Daily
The 3 Best Neuroscience Biotech Stocks to Buy Now
July 19, 2024
Via
InvestorPlace
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
July 06, 2024
Via
Talk Markets
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
Via
InvestorPlace
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
Via
Benzinga
Exposures
Product Safety
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
July 02, 2024
Via
Investor's Business Daily
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Via
Benzinga
Exposures
Product Safety
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
Via
Investor's Business Daily
Exposures
Product Safety
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
May 15, 2024
Via
Investor's Business Daily
Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?
April 24, 2024
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition
April 11, 2024
Via
InvestorPlace
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
3 Millionaire-Maker Stocks to Buy While the Gettin’ Is Good
February 12, 2024
Via
InvestorPlace
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
Via
Talk Markets
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
January 23, 2024
Via
InvestorPlace
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Via
Investor's Business Daily
3 Aging Population Stocks to Profit from the Boomer Generation
December 21, 2023
Via
InvestorPlace
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Via
Investor's Business Daily
3 Biotech Moonshots to Bet on the Future of Health
November 06, 2023
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.